Do analysts rate GCTK or DYNT?

Given Dynatronics' higher possible upside, analysts plainly believe Dynatronics is more favorable than GlucoTrack. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GlucoTrack 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is GCTK or DYNT more profitable?

GlucoTrack has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat GlucoTrack's return on equity. Company Net Margins Return on Equity Return on Assets GlucoTrack N/A -2,135.52% -290.22% Dynatronics -8.35% -41.81% -9.56%

Is DYNT or BTCY more profitable?

Dynatronics has a net margin of -8.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Dynatronics' return on equity. Company Net Margins Return on Equity Return on Assets Dynatronics -8.35% -41.81% -9.56% Biotricity -80.42% N/A -188.47%

Do analysts rate DYNT or VRAX?

Virax Biolabs Group has a consensus target price of $25.00, indicating a potential upside of 786.52%. Given Virax Biolabs Group's stronger consensus rating and higher possible upside, analysts plainly believe Virax Biolabs Group is more favorable than Dynatronics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Virax Biolabs Group 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, DYNT or VRAX?

Dynatronics has higher revenue and earnings than Virax Biolabs Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A Virax Biolabs Group $12.42K 180.92 -$5.02M N/A N/A

Do analysts recommend DYNT or TNON?

Given Dynatronics' higher probable upside, equities research analysts plainly believe Dynatronics is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is DYNT or TNON more profitable?

Dynatronics has a net margin of -8.35% compared to Tenon Medical's net margin of -257.85%. Dynatronics' return on equity of -41.81% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Dynatronics -8.35% -41.81% -9.56% Tenon Medical -257.85% -907.60% -124.84%

Do analysts recommend BBLG or DYNT?

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Bone Biologics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Dynatronics (DYNT) Competitors

Compare

DYNT vs. GCTK, BTCY, VRAX, TNON, and BBLG

Should you buy Dynatronics stock or one of its competitors? Dynatronics's main competitors and comparable companies include GlucoTrack (GCTK), Biotricity (BTCY), Virax Biolabs Group (VRAX), Tenon Medical (TNON), and Bone Biologics (BBLG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Dynatronics compare to GlucoTrack?

GlucoTrack (NASDAQ:GCTK) and Dynatronics (NASDAQ:DYNT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

GlucoTrack has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

In the previous week, GlucoTrack had 4 more articles in the media than Dynatronics. MarketBeat recorded 4 mentions for GlucoTrack and 0 mentions for Dynatronics. GlucoTrack's average media sentiment score of 0.22 beat Dynatronics' score of 0.00 indicating that GlucoTrack is being referred to more favorably in the media.

Company	Overall Sentiment
GlucoTrack	Neutral
Dynatronics	Neutral

GlucoTrack has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat GlucoTrack's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GlucoTrack	N/A	-2,135.52%	-290.22%
Dynatronics	-8.35%	-41.81%	-9.56%

Given Dynatronics' higher possible upside, analysts plainly believe Dynatronics is more favorable than GlucoTrack.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GlucoTrack	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

10.9% of GlucoTrack shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 5.9% of GlucoTrack shares are owned by company insiders. Comparatively, 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Dynatronics has higher revenue and earnings than GlucoTrack. GlucoTrack is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GlucoTrack	N/A	N/A	-$19.39M	-$9.18	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

Summary

GlucoTrack and Dynatronics tied by winning 7 of the 14 factors compared between the two stocks.

How does Dynatronics compare to Biotricity?

Dynatronics (NASDAQ:DYNT) and Biotricity (NASDAQ:BTCY) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by company insiders. Comparatively, 1.6% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Dynatronics has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Biotricity	$12.06M	0.21	-$14.09M	-$0.14	N/A

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.

Company	Overall Sentiment
Dynatronics	Neutral
Biotricity	Neutral

Dynatronics has a net margin of -8.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Biotricity	-80.42%	N/A	-188.47%

Dynatronics has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market. Comparatively, Biotricity has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market.

Summary

Dynatronics beats Biotricity on 7 of the 10 factors compared between the two stocks.

How does Dynatronics compare to Virax Biolabs Group?

Dynatronics (NASDAQ:DYNT) and Virax Biolabs Group (NASDAQ:VRAX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

In the previous week, Virax Biolabs Group had 2 more articles in the media than Dynatronics. MarketBeat recorded 2 mentions for Virax Biolabs Group and 0 mentions for Dynatronics. Virax Biolabs Group's average media sentiment score of 0.62 beat Dynatronics' score of 0.00 indicating that Virax Biolabs Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Dynatronics	Neutral
Virax Biolabs Group	Positive

Virax Biolabs Group has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Virax Biolabs Group's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Virax Biolabs Group	N/A	N/A	N/A

Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Virax Biolabs Group has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market.

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 8.6% of Virax Biolabs Group shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by company insiders. Comparatively, 45.1% of Virax Biolabs Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Dynatronics has higher revenue and earnings than Virax Biolabs Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Virax Biolabs Group	$12.42K	180.92	-$5.02M	N/A	N/A

Virax Biolabs Group has a consensus target price of $25.00, indicating a potential upside of 786.52%. Given Virax Biolabs Group's stronger consensus rating and higher possible upside, analysts plainly believe Virax Biolabs Group is more favorable than Dynatronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Virax Biolabs Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Virax Biolabs Group beats Dynatronics on 11 of the 13 factors compared between the two stocks.

How does Dynatronics compare to Tenon Medical?

Dynatronics (NASDAQ:DYNT) and Tenon Medical (NASDAQ:TNON) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

Dynatronics has a net margin of -8.35% compared to Tenon Medical's net margin of -257.85%. Dynatronics' return on equity of -41.81% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Tenon Medical	-257.85%	-907.60%	-124.84%

Dynatronics has higher revenue and earnings than Tenon Medical. Tenon Medical is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Tenon Medical	$5.31M	0.32	-$12.56M	-$44.87	N/A

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by company insiders. Comparatively, 17.7% of Tenon Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Dynatronics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market.

Given Dynatronics' higher probable upside, equities research analysts plainly believe Dynatronics is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tenon Medical had 7 more articles in the media than Dynatronics. MarketBeat recorded 7 mentions for Tenon Medical and 0 mentions for Dynatronics. Tenon Medical's average media sentiment score of 0.32 beat Dynatronics' score of 0.00 indicating that Tenon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Dynatronics	Neutral
Tenon Medical	Neutral

Summary

Dynatronics beats Tenon Medical on 8 of the 15 factors compared between the two stocks.

How does Dynatronics compare to Bone Biologics?

Bone Biologics (NASDAQ:BBLG) and Dynatronics (NASDAQ:DYNT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 5.6% of Bone Biologics shares are owned by insiders. Comparatively, 2.9% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Bone Biologics had 3 more articles in the media than Dynatronics. MarketBeat recorded 3 mentions for Bone Biologics and 0 mentions for Dynatronics. Bone Biologics' average media sentiment score of 0.57 beat Dynatronics' score of 0.00 indicating that Bone Biologics is being referred to more favorably in the media.

Company	Overall Sentiment
Bone Biologics	Positive
Dynatronics	Neutral

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Bone Biologics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Bone Biologics has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

Dynatronics has higher revenue and earnings than Bone Biologics. Bone Biologics is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bone Biologics	N/A	N/A	-$3.11M	-$1.37	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

Bone Biologics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bone Biologics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bone Biologics	N/A	-57.87%	-53.65%
Dynatronics	-8.35%	-41.81%	-9.56%

Summary

Bone Biologics and Dynatronics tied by winning 7 of the 14 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DYNT vs. The Competition

Export

Metric	Dynatronics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$653K	$5.78B	$7.18B	$12.88B
Dividend Yield	N/A	1.75%	2.54%	11.27%
P/E Ratio	-0.01	25.92	273.17	25.45
Price / Sales	N/A	78.92	638.13	103.78
Price / Cash	N/A	33.69	28.74	36.03
Price / Book	N/A	6.18	11.08	6.36
Net Income	-$2.70M	$149.94M	$3.48B	$349.79M

Dynatronics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DYNT Dynatronics	N/A	N/A	N/A	N/A	$653K	$33.60M	N/A	200
GCTK GlucoTrack	1.1223 of 5 stars	$0.33 -4.5%	N/A	-93.3%	$2.51M	N/A	N/A	5
BTCY Biotricity	N/A	$0.12 +1.7%	N/A	-77.0%	$2.36M	$12.06M	N/A	40	Gap Up
VRAX Virax Biolabs Group	2.4764 of 5 stars	$2.79 -4.1%	$25.00 +796.1%	-81.4%	$2.23M	$10K	N/A	5	Gap Up
TNON Tenon Medical	1.4414 of 5 stars	$5.23 -6.9%	N/A	-88.5%	$1.78M	$3.94M	N/A	8	Analyst Upgrade Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DYNT) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dynatronics (DYNT) Competitors

DYNT vs. GCTK, BTCY, VRAX, TNON, and BBLG

How does Dynatronics compare to GlucoTrack?

Summary

How does Dynatronics compare to Biotricity?

Summary

How does Dynatronics compare to Virax Biolabs Group?

Summary

How does Dynatronics compare to Tenon Medical?

Summary

How does Dynatronics compare to Bone Biologics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dynatronics (DYNT) Competitors

DYNT vs. GCTK, BTCY, VRAX, TNON, and BBLG

How does Dynatronics compare to GlucoTrack?

Which has more volatility & risk, GCTK or DYNT?

Does the media refer more to GCTK or DYNT?

Is GCTK or DYNT more profitable?

Do analysts rate GCTK or DYNT?

Do institutionals and insiders hold more shares of GCTK or DYNT?

Which has better earnings & valuation, GCTK or DYNT?

Summary

How does Dynatronics compare to Biotricity?

Do insiders & institutionals have more ownership in DYNT or BTCY?

Which has higher earnings & valuation, DYNT or BTCY?

Does the media favor DYNT or BTCY?

Is DYNT or BTCY more profitable?

Which has more volatility & risk, DYNT or BTCY?

Summary

How does Dynatronics compare to Virax Biolabs Group?

Does the media favor DYNT or VRAX?

Is DYNT or VRAX more profitable?

Which has more volatility & risk, DYNT or VRAX?

Do institutionals and insiders believe in DYNT or VRAX?

Which has higher earnings & valuation, DYNT or VRAX?

Do analysts rate DYNT or VRAX?

Summary

How does Dynatronics compare to Tenon Medical?

Is DYNT or TNON more profitable?

Which has higher earnings & valuation, DYNT or TNON?

Do insiders and institutionals have more ownership in DYNT or TNON?

Which has more volatility & risk, DYNT or TNON?

Do analysts recommend DYNT or TNON?

Does the media favor DYNT or TNON?

Summary

How does Dynatronics compare to Bone Biologics?

Do insiders and institutionals believe in BBLG or DYNT?

Does the media favor BBLG or DYNT?

Do analysts recommend BBLG or DYNT?

Which has more risk & volatility, BBLG or DYNT?

Which has better valuation & earnings, BBLG or DYNT?

Is BBLG or DYNT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools